SCHEMBL30801631

SCHEMBL30801631

CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCN(Cc5ccc(CCl)cc5)CC4)cn3)nc2n(C2CCCC2)c1=O

nearest known ligand 0.81

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CDK4 P11802 20/20 0.81
CDK6 Q00534 8/20 0.81
CCND3 P30281 12/20 0.78
CDK2 P24941 3/20 0.78
CCNA2 P20248 2/20 0.78
CDK9 P50750 2/20 0.78
CCND1 P24385 13/20 0.77
CCND2 P30279 11/20 0.77
CHEK1 O14757 1/20 0.74
DAPK3 O43293 1/20 0.74
CCNT1 O60563 1/20 0.74
CCNT2 O60583 1/20 0.74
ROCK2 O75116 1/20 0.74
STK16 O75716 1/20 0.74
CCNK O75909 1/20 0.74
PDE5A O76074 1/20 0.74
PRKD3 O94806 1/20 0.74
CCNB2 O95067 1/20 0.74
ABCB11 O95342 1/20 0.74
MAP4K4 O95819 1/20 0.74

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27217124 1.00 CDK4 (0.81) CDK4CDK6CCND3CDK2CCNA2
SCHEMBL31073308 0.96 CDK4 (0.82) CDK4CDK6CCND3CDK2CCNA2
SCHEMBL31073427 0.94 CDK4 (0.76) CDK4CDK6CCND3CDK2CCNA2
SCHEMBL31073023 0.92 CDK4 (0.78) CDK4CDK6CCND3CDK2CCNA2
SCHEMBL19021078 0.92 CDK4 (0.77) CDK4CDK6CCND3CDK2CCNA2
SCHEMBL31072952 0.91 CDK4 (0.73) CDK4CDK6CCND3CDK2CCNA2
SCHEMBL31073268 0.91 CDK4 (0.80) CDK4CDK6CCND3CDK2CCNA2
SCHEMBL31073357 0.91 CDK4 (0.77) CDK4CDK6CCND3CDK2CCNA2
SCHEMBL31073354 0.91 CDK4 (0.77) CDK4CDK6CCND3CDK2CCNA2
SCHEMBL31073224 0.91 CDK4 (0.76) CDK4CDK6CCND3CDK2CCNA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4584259-A1 CK1ALPHA AND DUAL CK1ALPHA / GSPT1 DEGRADING COMPOUNDS Innovo Therapeutics, Inc. (US) 2025-07-16 EP disclosed
WO-2024173646-A1 CYCLIN-DEPENDENT KINASE DEGRADING COMPOUNDS INNOVO THERAPEUTICS, INC. (US) 2024-08-22 WO disclosed
WO-2024054832-A1 CK1α AND DUAL CK1α / GSPT1 DEGRADING COMPOUNDS INNOVO THERAPEUTICS, INC. (US) 2024-03-14 WO disclosed